SI1468686T1 - S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj - Google Patents

S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj

Info

Publication number: SI1468686T1
Authority: SI; Slovenia
Prior art keywords: ziprasidone; dihydro; methyl; treatment; psychiatric disorders
Prior art date: 2000-06-02

Application number

SI200130681T

Other languages

English (en)

Inventor

Chandra Pfizer Global Prakash

Teresa Annette Pfizer Smolarek

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2001-05-28

Publication date

2007-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1468686(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2007-04-30 Publication of SI1468686T1 publication Critical patent/SI1468686T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)

SI200130681T 2000-06-02 2001-05-28 S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj SI1468686T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20913600P	2000-06-02	2000-06-02
US21217200P	2000-06-16	2000-06-16
EP04013380A EP1468686B1 (en)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders

Publications (1)

Publication Number	Publication Date
SI1468686T1 true SI1468686T1 (sl)	2007-04-30

Family

ID=26903852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200130681T SI1468686T1 (sl)	2000-06-02	2001-05-28	S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj

Country Status (44)

Country	Link
US (1)	US20060287336A1 (sl)
EP (3)	EP1286672B1 (sl)
JP (2)	JP2003534381A (sl)
KR (1)	KR20030007824A (sl)
CN (1)	CN1431901A (sl)
AP (2)	AP1747A (sl)
AR (1)	AR028937A1 (sl)
AT (3)	ATE391507T1 (sl)
AU (1)	AU2001258690A1 (sl)
BG (1)	BG107267A (sl)
BR (1)	BR0111271A (sl)
CA (1)	CA2410618A1 (sl)
CY (1)	CY1105992T1 (sl)
CZ (1)	CZ20023860A3 (sl)
DE (3)	DE60133596D1 (sl)
DK (1)	DK1468686T3 (sl)
DO (1)	DOP2001000181A (sl)
EA (1)	EA007068B1 (sl)
EC (1)	ECSP024369A (sl)
EE (1)	EE200200670A (sl)
ES (1)	ES2277170T3 (sl)
GE (1)	GEP20053512B (sl)
HN (1)	HN2001000119A (sl)
HR (1)	HRP20020953A2 (sl)
HU (1)	HUP0301747A2 (sl)
IL (2)	IL152782A0 (sl)
IS (1)	IS6619A (sl)
MA (1)	MA26908A1 (sl)
MX (1)	MXPA02011862A (sl)
NO (1)	NO325077B1 (sl)
NZ (1)	NZ551012A (sl)
OA (1)	OA12267A (sl)
PA (1)	PA8518301A1 (sl)
PE (1)	PE20011329A1 (sl)
PL (1)	PL365576A1 (sl)
PT (2)	PT1698338E (sl)
SI (1)	SI1468686T1 (sl)
SK (1)	SK16622002A3 (sl)
SV (1)	SV2002000473A (sl)
UA (1)	UA79425C2 (sl)
UY (1)	UY26742A1 (sl)
WO (1)	WO2001091756A2 (sl)
YU (1)	YU90702A (sl)
ZA (1)	ZA200209665B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003296991A1 (en)	2002-12-13	2004-07-09	Regents Of The University Of Minnesota	Scleral depressor
WO2005040160A2 (en)	2003-10-24	2005-05-06	Teva Pharmaceutical Industries Ltd.	Processes for preparation of ziprasidone
ES2250001B1 (es) *	2004-09-29	2007-06-01	Medichem, S.A.	Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) *	2011-02-24	2012-09-10	Kyocera Corp	プログラム保護装置および通信装置
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
US9981041B2 (en) *	2016-08-23	2018-05-29	Ira Jason Salzman	Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU229057B1 (en) *	1996-05-07	2013-07-29	Pfizer	Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (-ziprasidone), its preparation and its use as dopamine d2 antagonist
TW491847B (en) *	1996-05-07	2002-06-21	Pfizer	Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
EP0985414B1 (en) *	1998-05-26	2003-08-27	Pfizer Products Inc.	Medicament for the treatment of glaucoma and ischemic retinopathy
CA2363942A1 (en) *	1999-04-06	2000-10-12	Sepracor Inc.	Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites

2001
- 2001-05-28 EP EP01932011A patent/EP1286672B1/en not_active Expired - Lifetime
- 2001-05-28 AU AU2001258690A patent/AU2001258690A1/en not_active Abandoned
- 2001-05-28 DE DE60133596T patent/DE60133596D1/de not_active Expired - Lifetime
- 2001-05-28 IL IL15278201A patent/IL152782A0/xx active IP Right Grant
- 2001-05-28 NZ NZ551012A patent/NZ551012A/en unknown
- 2001-05-28 KR KR1020027016364A patent/KR20030007824A/ko not_active Application Discontinuation
- 2001-05-28 DK DK04013380T patent/DK1468686T3/da active
- 2001-05-28 CA CA002410618A patent/CA2410618A1/en not_active Abandoned
- 2001-05-28 PT PT06116051T patent/PT1698338E/pt unknown
- 2001-05-28 JP JP2001587771A patent/JP2003534381A/ja not_active Withdrawn
- 2001-05-28 GE GE4972A patent/GEP20053512B/en unknown
- 2001-05-28 EA EA200201168A patent/EA007068B1/ru not_active IP Right Cessation
- 2001-05-28 AT AT06116051T patent/ATE391507T1/de not_active IP Right Cessation
- 2001-05-28 MX MXPA02011862A patent/MXPA02011862A/es active IP Right Grant
- 2001-05-28 ES ES04013380T patent/ES2277170T3/es not_active Expired - Lifetime
- 2001-05-28 YU YU90702A patent/YU90702A/sh unknown
- 2001-05-28 DE DE60124093T patent/DE60124093D1/de not_active Expired - Lifetime
- 2001-05-28 UA UA2002119557A patent/UA79425C2/uk unknown
- 2001-05-28 SK SK1662-2002A patent/SK16622002A3/sk not_active Application Discontinuation
- 2001-05-28 EE EEP200200670A patent/EE200200670A/xx unknown
- 2001-05-28 WO PCT/IB2001/000933 patent/WO2001091756A2/en active IP Right Grant
- 2001-05-28 CN CN01810620A patent/CN1431901A/zh active Pending
- 2001-05-28 PT PT04013380T patent/PT1468686E/pt unknown
- 2001-05-28 PL PL01365576A patent/PL365576A1/xx unknown
- 2001-05-28 BR BR0111271-6A patent/BR0111271A/pt not_active Application Discontinuation
- 2001-05-28 SI SI200130681T patent/SI1468686T1/sl unknown
- 2001-05-28 OA OA1200200349A patent/OA12267A/en unknown
- 2001-05-28 DE DE60124791T patent/DE60124791T2/de not_active Expired - Fee Related
- 2001-05-28 AT AT04013380T patent/ATE345818T1/de not_active IP Right Cessation
- 2001-05-28 CZ CZ20023860A patent/CZ20023860A3/cs unknown
- 2001-05-28 EP EP06116051A patent/EP1698338B1/en not_active Expired - Lifetime
- 2001-05-28 HU HU0301747A patent/HUP0301747A2/hu unknown
- 2001-05-28 AT AT01932011T patent/ATE343387T1/de not_active IP Right Cessation
- 2001-05-28 EP EP04013380A patent/EP1468686B1/en not_active Expired - Lifetime
- 2001-05-31 DO DO2001000181A patent/DOP2001000181A/es unknown
- 2001-05-31 HN HN2001000119A patent/HN2001000119A/es unknown
- 2001-05-31 AP AP2005003272A patent/AP1747A/xx active
- 2001-05-31 UY UY26742A patent/UY26742A1/es not_active Application Discontinuation
- 2001-05-31 AP APAP/P/2001/002180A patent/AP1831A/en active
- 2001-05-31 PE PE2001000504A patent/PE20011329A1/es not_active Application Discontinuation
- 2001-06-01 AR ARP010102641A patent/AR028937A1/es unknown
- 2001-06-01 SV SV2001000473A patent/SV2002000473A/es not_active Application Discontinuation
- 2001-06-01 PA PA20018518301A patent/PA8518301A1/es unknown
- 2001-06-04 US US09/873,973 patent/US20060287336A1/en not_active Abandoned
2002
- 2002-11-11 IL IL152782A patent/IL152782A/en not_active IP Right Cessation
- 2002-11-12 BG BG107267A patent/BG107267A/bg unknown
- 2002-11-14 IS IS6619A patent/IS6619A/is unknown
- 2002-11-28 ZA ZA200209665A patent/ZA200209665B/en unknown
- 2002-11-29 EC EC2002004369A patent/ECSP024369A/es unknown
- 2002-11-29 MA MA26927A patent/MA26908A1/fr unknown
- 2002-11-29 NO NO20025760A patent/NO325077B1/no unknown
- 2002-12-02 HR HR20020953A patent/HRP20020953A2/hr not_active Application Discontinuation
2007
- 2007-02-08 CY CY20071100161T patent/CY1105992T1/el unknown
- 2007-11-14 JP JP2007296039A patent/JP2008056700A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
HRP20020953A2 (en)	2005-02-28
DE60124791T2 (de)	2007-09-13
US20060287336A1 (en)	2006-12-21
ZA200209665B (en)	2003-11-28
ATE345818T1 (de)	2006-12-15
GEP20053512B (en)	2005-05-10
NO20025760D0 (no)	2002-11-29
AR028937A1 (es)	2003-05-28
JP2003534381A (ja)	2003-11-18
BG107267A (bg)	2003-06-30
CZ20023860A3 (cs)	2004-01-14
EP1698338A2 (en)	2006-09-06
IL152782A0 (en)	2003-06-24
EP1698338A3 (en)	2006-09-20
EE200200670A (et)	2004-08-16
WO2001091756A2 (en)	2001-12-06
HUP0301747A2 (hu)	2003-09-29
PT1698338E (pt)	2008-06-03
HN2001000119A (es)	2001-09-11
PL365576A1 (en)	2005-01-10
DE60133596D1 (de)	2008-05-21
NO20025760L (no)	2003-01-15
PA8518301A1 (es)	2002-09-17
DK1468686T3 (da)	2007-03-12
DE60124093D1 (de)	2006-12-07
IS6619A (is)	2002-11-14
BR0111271A (pt)	2003-06-10
AP1747A (en)	2007-05-31
IL152782A (en)	2007-10-31
DE60124791D1 (de)	2007-01-04
EA200201168A1 (ru)	2003-06-26
KR20030007824A (ko)	2003-01-23
YU90702A (sh)	2005-11-28
AP2005003272A0 (en)	2005-03-31
EP1468686A3 (en)	2004-12-01
NO325077B1 (no)	2008-01-28
CY1105992T1 (el)	2011-04-06
EP1698338B1 (en)	2008-04-09
ES2277170T3 (es)	2007-07-01
ECSP024369A (es)	2003-02-06
SK16622002A3 (sk)	2004-07-07
OA12267A (en)	2004-01-20
AP1831A (en)	2008-02-26
DOP2001000181A (es)	2002-04-15
CN1431901A (zh)	2003-07-23
JP2008056700A (ja)	2008-03-13
PE20011329A1 (es)	2002-01-15
EP1286672A2 (en)	2003-03-05
ATE343387T1 (de)	2006-11-15
MXPA02011862A (es)	2003-04-10
EP1286672B1 (en)	2006-10-25
UA79425C2 (en)	2007-06-25
NZ551012A (en)	2008-04-30
UY26742A1 (es)	2001-12-28
WO2001091756A3 (en)	2002-09-26
ATE391507T1 (de)	2008-04-15
PT1468686E (pt)	2007-01-31
AU2001258690A1 (en)	2001-12-11
MA26908A1 (fr)	2004-12-20
SV2002000473A (es)	2002-10-24
CA2410618A1 (en)	2001-12-06
EA007068B1 (ru)	2006-06-30
EP1468686B1 (en)	2006-11-22
EP1468686A2 (en)	2004-10-20

Publication	Publication Date	Title
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
EP1274444A4 (en)	2006-06-14	DRUGS FOR THE TREATMENT OF PSYCHIATRICAL OR ABUSUS-RELATED DISORDER
AU8187701A (en)	2002-01-14	Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
IL151890A0 (en)	2003-04-10	Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU2001271887A1 (en)	2002-01-21	Methods for diagnosis and treatment of psychiatric disorders
IL151765A0 (en)	2003-04-10	Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en)	2003-04-10	Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB9926968D0 (en)	2000-01-12	Treatment of neurological disorders
AU8333701A (en)	2002-02-25	Method of treating angiogenesis-related disorders
IL155874A0 (en)	2003-12-23	Treatment of anxiety disorders
SI1468686T1 (sl)	2007-04-30	S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj
AU7388101A (en)	2001-12-24	Indole derivatives useful for the treatment of cns disorders
IL154378A0 (en)	2003-09-17	Compounds for the treatment of addictive disorders
AU8173801A (en)	2002-02-05	Indole derivatives useful for the treatment of cns disorders
IL153254A0 (en)	2003-07-06	Indole derivatives useful for the treatment of cns disorders
GB0010496D0 (en)	2000-06-14	Treatment of conditions of the central nervous system
GB0029955D0 (en)	2001-01-24	Treatment of neuropsychiatric disorders
GB0017951D0 (en)	2000-09-13	Treatment of movement disorders
GB9924942D0 (en)	1999-12-22	Treatment of movement disorders
AU2002310292A1 (en)	2002-12-16	Novel treatment for neurological and psychiatric disorders
GB9923551D0 (en)	1999-12-08	Treatment of neuropsychiatric disorders
GB9918058D0 (en)	1999-10-06	Compound for treatment of gi disorders
GB0003228D0 (en)	2000-04-05	Treatment of GI disorders
GB0125371D0 (en)	2001-12-12	Treatment of movement disorders